| SELECTIS HEALTH, INC. (GBCSD) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q2-CY2026 | Q1-CY2026 | Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | |
| Balance Sheet Date | 2025-Dec-31 | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2021-Mar-31 | 2020-Mar-31 | 2019-Mar-31 | 2018-Mar-31 | 2017-Mar-31 | 2016-Mar-31 | 2015-Mar-31 | |||||||||||||||||||||||||||||||||
| Fiscal Period | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q3-FY2021 | Q3-FY2020 | Q3-FY2019 | Q3-FY2018 | Q3-FY2017 | Q3-FY2016 | Q3-FY2015 | |||||||||||||||||||||||||||||||||
| Price to Sales | |||||||||||||||||||||||||||||||||||||||||||||||||
| Price to Book | |||||||||||||||||||||||||||||||||||||||||||||||||
| Price to Earnings | |||||||||||||||||||||||||||||||||||||||||||||||||
| Price to Unlevered FCF | |||||||||||||||||||||||||||||||||||||||||||||||||
| Debt to Asset Ratio | 1.19x | 1.17x | 1.19x | 1.18x | 1.16x | 1.14x | 1.09x | 1.10x | 1.07x | .98x | .92x | .93x | .96x | .96x | .99x | .99x | .97x | .97x | .97x | .97x | .96x | .95x | .94x | .94x | .90x | .90x | .89x | .88x | .86x | .90x | .91x | .89x | .83x | .83x | .83x | .80x | .72x | .62x | |||||||||||
| Current Ratio | .30x | .19x | .19x | .22x | .18x | .17x | .33x | .23x | .27x | .72x | .40x | .28x | |||||||||||||||||||||||||||||||||||||